Effect of psycho-educational intervention on hot flushes and related symptoms after treatment for localised breast cancer
- Conditions
- Hot flushes in women with previous localised breast cancerCancer - Breast
- Registration Number
- ACTRN12606000186550
- Lead Sponsor
- Supportive Care Research Group at the Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 25
Localised breast cancer (Stage I, II & III); Adjuvant therapy (surgery ± chemotherapy ± radiotherapy) completed for more than 3 months but no more than 5 years (may take tamoxifen or aromatase inhibitor but no modification allowed during the time of the study); Have HF (³ 5 / 24 hours).
Women taking pharmacological medications for HF; Women with severe depression who are currently seeing a psychiatrist or taking antidepressants for < 3 months; Women currently undergoing cognitive-behavioural therapy; Women cognitively impaired.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of hot flushes measured with a hot flushes diary where each hot flush and its severity will be recorded for 7 days at each timepoint.[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after). ];Daily hot flush score (frequency x severity score for each HF) measured with a hot flushes diary where each hot flush and its severity will be recorded for 7 days at each timepoint.[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after). ]
- Secondary Outcome Measures
Name Time Method Changes in interference of hot flushes with different aspects of life[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after).];Changes in sleep, fatigue, anxiety and mood disturbance[Measured twice before the intervention (at 4 weeks apart) and twice after the intervention (at the end of the intervention and 3 months after).]